

share
Suvizumab CAS NO 914257-21-9
Unit Price:
CAS No.:914257-21-9
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Suvizumab CAS NO 914257-21-9 is a high-purity monoclonal antibody (mAb) designed for targeted therapeutic applications. This compound is critical for research and development in advanced biopharmaceuticals, offering precise biological activity. It is primarily utilized by pharmaceutical developers, contract research organizations (CROs), and academic institutions engaged in oncology and immunology research.
Application
- Primary active pharmaceutical ingredient (API) in targeted cancer therapy formulations.
- Key reagent in preclinical and clinical research for studying specific antigen pathways.
- Critical component in the development of novel antibody-drug conjugates (ADCs).
- Used as a reference standard in bioanalytical method development and validation.
- Essential material for quality control and potency assays in biomanufacturing.
- Tool compound for investigating mechanisms of action in immunological disorders.
Basic Information
| Item | Detail |
|---|---|
| Product Name | Suvizumab |
| CAS No. | 914257-21-9 |
| Molecular Formula | Contact for details |
| Molecular Weight | Contact for details |
| Synonyms | Anti-[Target] Monoclonal Antibody; Suvizumab mAb; Therapeutic Antibody 914257-21-9; [Target]-specific IgG; Immunoglobulin G1, anti-[Target]; Monoclonal Antibody to [Target]; [Target] Inhibitor Antibody |
| EINECS | Contact for details |
Quality Control
Our Suvizumab is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including purity assessment by HPLC-SEC, potency analysis, and stringent endotoxin and bioburden controls to ensure it meets pharmaceutical-grade standards. A detailed Certificate of Analysis (COA) documenting identity, purity, and activity is provided with every shipment.
Storage
Preserve in a tightly closed container, protected from light. For long-term stability, store frozen at -20°C to -80°C. Avoid repeated freeze-thaw cycles. This product is hygroscopic (moisture-sensitive) and strictly light-sensitive (protect from all light exposure). Allow to equilibrate to room temperature before opening to minimize moisture uptake.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white lyophilized powder or clear solution |
| Identification (HPLC) | Conforms to reference standard |
| Purity (HPLC-SEC) | ≥ 98.0% (Monomer) |
| Protein Content (UV) | 95.0 - 105.0 % of label claim |
| Potency (Cell-based Assay) | ≥ 90% relative activity |
| Endotoxin | < 1.0 EU/mg |
| Host Cell Protein | < 100 ppm |
| Sterility (Membrane Filtration) | Sterile |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Pembrolizumab CAS NO 1374853-91-4


Tuvirumab CAS NO 138660-97-6


Biciromab CAS NO 138783-13-8


Muromonab-Cd3 CAS NO 140608-64-6


Anti-Stromelysin-2 CAS NO 140610-48-6


Gendevit CAS NO 141910-80-7


Edrecolomab CAS NO 156586-89-9


Felvizumab CAS NO 167747-20-8


Faralimomab CAS NO 167816-91-3


Rovelizumab [Usan:Inn] CAS NO 197099-66-4


Teprotumumab CAS NO 1036734-93-6


Monalizumab CAS NO 1228763-95-8


Anifrolumab CAS NO 1326232-46-5


Anti-Br140-Like Protein Antibody Produced In Rabbit CAS NO 1597439-92-3


Eptinezumab CAS NO 1644539-04-7


Rhumab Cd 168 CAS NO 211323-03-4


Ociperlimab CAS NO 2342597-93-5


Tadocizumab CAS NO 339086-80-5


Galiximab CAS NO 357613-77-5


Tocilizumab CAS NO 375823-41-9
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






